Satsuma Pharmaceuticals

/Satsuma Pharmaceuticals

We are a clinical-stage biopharmaceutical company developing a novel therapeutic product for the acute treatment of migraine.

Symbol

Price Range
$14.00 - $16.00

Final Shares
5,000,000

Anticipated Date
September 13, 2019

Underwriters

This offering is no longer available

To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange